5601 - 5610 of 8587 Results
Title
Year
-
RESTRICTEDTitle: Monoamine transporter contributions to l-DOPA effects in hemi-parkinsonian ratsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 110Issue #:Start Page: 125End Page: 134Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2016.07.025Citation Count: 26
-
OPENTitle: Lrrk2 p.Q1111H substitution and Parkinson’s disease in Latin AmericaJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 17Issue #: 8Start Page: 629End Page: 631Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2011.05.003Best OA location URL: https://repositorio.uchile.cl/handle/2250/165323Citation Count: 17
-
OPENTitle: Understanding what aspects of Parkinson’s disease matter most to patients and familiesJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41598-024-71555-4Best OA location URL: https://www.nature.com/articles/s41598-024-71555-4.pdfCitation Count: 8
-
OPENTitle: Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapyJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-018-0245-9Best OA location URL: http://link.springer.com/content/pdf/10.1186/s13024-018-0245-9.pdfCitation Count: 65
-
RESTRICTEDTitle: Protective Effects of Lovastatin in a Population‐BasedALSStudy and Mouse ModelJournal Name: Annals of NeurologyPublisher: WileyVol: 93Issue #: 5Start Page: 881End Page: 892Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.26600Citation Count: 5
-
RESTRICTEDTitle: PPMI 2.O New Science/New Cohorts - Transforming PPMI (2490)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.2490Citation Count: 7
-
RESTRICTEDTitle: PDE10A and ADCY5 mutations linked to molecular and microstructural basal ganglia pathologyJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 12Start Page: 1961End Page: 1965Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27523Citation Count: 43
-
RESTRICTEDTitle: What Parkinson's disease patients say in their own words about their mood and anxiety symptomsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 130Issue #:Start Page: 107190End Page: 107190Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107190Citation Count: 0
- Singing in groups for Parkinson's disease (SING-PD): A pilot study of group singing therapy for PD-related voice/speech disorders2012RESTRICTEDTitle: Singing in groups for Parkinson's disease (SING-PD): A pilot study of group singing therapy for PD-related voice/speech disordersJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 18Issue #: 5Start Page: 548End Page: 552Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2012.02.009Citation Count: 65
- Neuromodulation targets pathological not physiological beta bursts during gait in Parkinson's disease2018OPENTitle: Neuromodulation targets pathological not physiological beta bursts during gait in Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 120Issue #:Start Page: 107End Page: 117Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2018.09.004Citation Count: 125